
Antibody Solutions
Antibody Solutions is a premier developer of therapeutic, diagnostic and critical reagent antibodies. Our platforms include human antibodies from transgenic OmniRats™, Hybridoma Libraries™, and high-throughput flow-cytometry screening of cell-associated targets. We provide full technical support and project management with all services performed in the USA.
John Kenney
President
Ascendia Pharmaceuticals, LLC
Ascendia is a specialty pharmaceutical company dedicated to developing enhanced formulations of existing drug products, and enabling formulations for pre-clinical and clinical stage drug candidates. We use our nano-particle technologies and expertise to improve the bioavailability of poorly water soluble compounds.
At Ascendia, our core business is to develop proprietary product formulations for poorly water soluble drugs in order to bring value to our pharmaceutical company partners. We provide practical, customized formulation solutions that enable advancement of compounds from discovery to clinical testing. We offer rapid and cost-effective formulation technology screening services for poorly water soluble drugs through the utilization of our multiple nano-particle technologies. We provide trial formulations suitable for initial animal studies, toxicology studies and Phase I clinical trials using nano-emulsion, amorphous solid dispersion, and particle size reduction approaches. We conduct development program support for novel life-cycle management products based on these technology platforms.
BioFocus, A Charles River Company
Charles River discovery offers a truly integrated approach to small molecule drug discovery, uniting all of the key disciplines required to achieve a program's goals in a single project team. With the acquisition of BioFocus, Argenta and Chantest, the CRL Discovery organization can integrate medicinal chemistry, physical sciences, CADD, in vitro biology, HTS, structural biology, ADMET/PK and disease models as required.
Barbara Carlilse
Director Business Development
DavosPharma
DavosPharma’s corporate offering covers all the activities required to get a drug from conception to commercialization. DavosPharma has been filling this need since 1972, serving the pharmaceutical and life science market by providing discovery chemistry & biology, pre-clinical development, and all required CMC activities including custom synthesis of organic molecules, custom dosage formulation, and custom manufacturing of cGMP intermediates, APIs, and drug product.
Gifford Marzoni
Vice-President Global Pharmaceutical DevelopmentMike Shore
Director, Global Supply Chain & Technical Operations
Pharmatek
Pharmatek is a contract development & manufacturing company providing dosage form development & cGMP manufacturing of oral, injectable & topical products. Founded in 1999, our services focus on the rapid advancement of small molecule & peptide drug candidates from the bench to the clinic & include:
· Formulation & Analytical Development
· cGMP Manufacturing
· Clinical Packaging, Labeling & Worldwide Distribution
Our experience includes first-in-man strategies, solutions for poorly soluble compounds, controlled release formulations & separate facilities for the handling of cytotoxic & potent compounds. Pharmatek’s drug delivery technologies include:
· Solid Dispersions
· Particle Size Reduction
· Lipid Delivery
· Complexation
· Lyophilization
· Suspensions & Emulsions
Pharmatek’s 68,000 sq. ft. facility includes 9 class 100,000 cGMP manufacturing suites, formulation & analytical laboratories, & ICH stability storage. Pharmatek has over 150 clients globally, ranging from virtual to large pharmaceutical companies. Having manufactured product for clinical trials in the North America, Europe & Asia; Pharmatek has successfully completed several large pharma quality, EH&S & QP audits.

Symbient Product Development
Rapid Development of Injection Molded Medical Devices
From Concept Through Transfer-to-Manufacturing
Symbient specializes in engineering research and development, prototyping and design-for-manufacturing of innovative medical devices that use injection molded components. Our highly experienced team consists of mechanical and biomedical engineers, industrial designers, machinists and molding technicians. They leverage our in-house rapid prototyping, and prototype tooling fabrication and injection molding to create proven, manufacturable designs with unmatched speed, efficiency and precision. These designs make up our deep portfolio of over 300 successful devices that have collectively generated hundreds of millions of dollars. They include FDA Class I, II and III devices, developed under our ISO 13485 certified quality management system.
Our Services Include:
- Concept Development
- Development Engineering
- Design-for-Manufacturing
- Industrial Design
- Project Rescue
- Design Control per IOS 13485
- Finite Element Analysis (FEA)
- Design Verification Testing
- Test Method Development
- Transfer to Manufacturing
Our In-House Capabilities and Expertise Include:
- Stereolithography (SLA) Prototyping
- CNC Machining / Fabrication
- Prototype Mold Fabrication
- Prototype Injection Molding of Devices for Testing, Trials and Studies
- Liquid Injection Molded (LIM) Silicone Prototype Molding
- Product Reliability Testing
- Plastics Assembly Expertise: Ultrasonic and Laser Welding, Heat Sealing, Pressure Sensitive Adhesives, Swaging, Snap Fits, Press Fits, Interlocks.
- Speed: Prototype Molds in as little as 1 week and Modifications in as little as 1 Day
- Material Selection Expertise, Research and Testing to Ensure All Product Requirements Are Met.
Our Portfolio Includes:
- Diagnostics / Molecular Diagnostics
- Sample collection / preparation
- Life Sciences / Microfluidics
- OTC Consumer products
- Respiratory
- Surgical devices and clinical tools
- Drug Delivery